Dedicated to our memory of Christopher Finnes and Nicholas D’Amora who inspired so many in their short but extraordinary lives Empowering Voices: A Community-Directed Panel Discussion on Epilepsy in Autism As an organization committed to serving individuals with autism, we understand the unique...
New Perspectives on Healing Chronic Diseases – a paper by Dr Naviaux In a paper published May 10, 2023 ‘Mitochondrial and metabolic features of salugenesis and the healing cycle’ Dr Robert Naviaux, professor of Medicine, Pediatrics and Pathology at UC San Diego whose work has been supported...
The BRAIN Foundation at Paxmedica’s NASDAQ Closing Bell Event It was a great honor for The BRAIN Foundation to join the PaxMedica team as they rang the NASDAQ Closing Bell last week. PaxMedica is is a clinical-stage biopharmaceutical company spearheading the development of innovative...
Synchrony 2022 Roundtable Publication: Epilepsy and Seizures in Autism We are happy to share that a summary paper has been published on Synchrony Symposia 2022 SEIZURES IN AUTISM Roundtable, one of the four discussions that took place during the event that focused on some of the most difficult and...
Synchrony 2023 – Call for Abstracts Synchrony 2023 Call for Abstracts is now closed. Sign up to our mailing list to be notified of future opportunities and events What is Synchrony? Synchrony is the first and only international symposium on translational research in autism that brings...
The BRAIN Foundation Industry Seed Investment in Jelikalite The BRAIN Foundation is happy to announce our seed investment in JelikaLite for a total raise of $760,000 along with our co-investors. JelikaLite is a medical technology company with a focus on neurological health in pediatric population...
Synchrony 2022 Meeting Report: Catalyzing Research and Treatments The paper summarizing our latest Synchrony Symposia was published in March 2023 edition of the Journal of Personalized Medicine. Synchrony 2022 brought together both basic and clinical sciences from both academia and industry to...